Skip to main content
    Z

    Zoetis Inc (ZTS)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NYSE

    $84.42
    +0.61 (+0.72%)

    Market Cap: $34.06B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Zoetis Inc (ZTS) Financials: Revenue, Profit and Cash Flow

    Updated Nov 5, 2026. Financial statements from company filings, amounts in US dollars.

    Zoetis reported revenue of $9.47B for the fiscal year ended Dec 31, 2025, up 2.3% from the year before. That year, net income was $2.67B with a net margin of 28.2%, operating cash flow was $2.90B and free cash flow was $2.28B. The quarter ended Sep 30, 2026 had revenue of $2.39B and net income of $591.00M.

    Revenue and Margins

    The operating margin was 37.5% in the fiscal year ended Dec 2025, the highest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $4.89B, a compound annual rate of 7.6%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$9.47B+2.3%71.8%37.5%28.2%
    Dec 2024$9.26B+8.3%70.6%36.1%27.0%
    Dec 2023$8.54B+5.7%70.0%35.3%27.4%
    Dec 2022$8.08B+3.9%69.6%36.1%26.1%
    Dec 2021$7.78B+16.5%70.4%35.5%26.2%
    Dec 2020$6.67B+6.6%69.2%33.6%24.5%
    Dec 2019$6.26B+7.5%68.2%31.4%24.0%
    Dec 2018$5.83B+9.8%67.2%31.1%24.4%
    Dec 2017$5.31B+8.6%66.6%32.1%16.2%
    Dec 2016$4.89BN/A65.9%28.5%16.8%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income rose 6.8% from the year before. In the quarter ended Sep 2026, net income fell 18.0% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$9.47B$9.26B$8.54B$8.08B$7.78B$6.67B$6.26B$5.83B$5.31B$4.89B
    Cost of revenue$2.67B$2.72B$2.56B$2.45B$2.30B$2.06B$1.99B$1.91B$1.77B$1.67B
    Gross profit$6.80B$6.54B$5.98B$5.63B$5.47B$4.62B$4.27B$3.91B$3.53B$3.22B
    Research and development$698.00M$686.00M$614.00M$539.00M$508.00M$463.00M$457.00M$432.00M$382.00M$376.00M
    Operating income$3.55B$3.34B$3.02B$2.92B$2.76B$2.24B$1.97B$1.81B$1.71B$1.39B
    Net income$2.67B$2.50B$2.34B$2.11B$2.03B$1.64B$1.50B$1.42B$862.00M$819.00M
    EBITDA$4.07B$3.85B$3.67B$3.34B$3.16B$2.67B$2.44B$2.20B$1.94B$1.63B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$2.39B$2.47B$2.26B$2.39B$2.42B$2.47B$2.20B$2.32B$2.39B$2.36B$2.19B$2.21B
    Gross profit$1.69B$1.79B$1.62B$1.68B$1.73B$1.81B$1.58B$1.61B$1.69B$1.69B$1.55B$1.49B
    Operating income$863.00M$922.00M$800.00M$809.00M$932.00M$967.00M$812.00M$763.00M$915.00M$864.00M$797.00M$701.00M
    Net income$591.00M$691.00M$601.00M$603.00M$721.00M$726.00M$602.00M$581.00M$692.00M$624.00M$599.00M$523.00M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $9.04B exceeded cash and equivalents by $6.59B.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$15.49B$14.24B$14.29B$14.93B$13.90B$13.61B$11.54B$10.78B$8.59B$7.65B
    Current assets$6.77B$5.99B$6.34B$7.51B$6.93B$6.61B$4.75B$4.40B$4.22B$3.39B
    Cash and equivalents$2.45B$1.99B$2.04B$3.58B$3.48B$3.60B$1.93B$1.60B$1.56B$727.00M
    Total liabilities$12.07B$9.47B$9.29B$10.52B$9.36B$9.84B$8.84B$8.59B$6.80B$6.15B
    Short-term debt$0$1.35B$3.00M$1.35B$0$604.00M$500.00M$9.00M$0$4.47B
    Long-term debt$9.04B$5.22B$6.56B$6.55B$6.59B$6.59B$5.95B$6.44B$4.95B$4.47B
    Shareholder equity$3.42B$4.77B$5.00B$4.41B$4.54B$3.77B$2.71B$2.19B$1.77B$1.49B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$15.09B$15.08B$15.15B$15.47B$15.16B$14.48B$14.10B$14.24B$14.36B$14.16B$14.35B$14.29B
    Total liabilities$11.79B$11.93B$11.92B$12.14B$9.76B$9.50B$9.44B$9.47B$9.12B$9.21B$9.30B$9.29B
    Cash and equivalents$1.33B$1.48B$1.94B$2.31B$2.08B$1.44B$1.72B$1.99B$1.71B$1.57B$1.98B$2.04B
    Shareholder equity$3.30B$3.15B$3.23B$3.33B$5.40B$4.98B$4.66B$4.77B$5.23B$4.97B$5.06B$5.00B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 78.6% of operating cash flow. Dividends and share repurchases together came to 180.7% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$2.90B$2.95B$2.35B$1.91B$2.21B$2.13B$1.79B$1.79B$1.35B$713.00M
    Capital expenditures$621.00M$655.00M$732.00M$586.00M$477.00M$453.00M$460.00M$338.00M$224.00M$216.00M
    Free cash flow$2.28B$2.30B$1.62B$1.33B$1.74B$1.67B$1.33B$1.45B$1.12B$497.00M
    Dividends paid$889.00M$786.00M$692.00M$611.00M$474.00M$377.00M$314.00M$269.00M$249.00M$188.00M
    Share repurchases$3.23B$1.86B$1.09B$1.59B$743.00M$250.00M$626.00M$698.00M$500.00M$300.00M
    Investing cash flow-$748.00M-$315.00M-$777.00M-$883.00M-$458.00M-$572.00M-$504.00M-$2.26B-$270.00M-$214.00M
    Financing cash flow-$1.87B-$2.66B-$3.11B-$904.00M-$1.86B$123.00M-$951.00M$533.00M-$251.00M-$903.00M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$824.00M$655.00M$401.00M$893.00M$936.00M$605.00M$515.00M$905.00M$951.00M$502.00M$595.00M$897.00M
    Capital expenditures$107.00M$117.00M$110.00M$161.00M$138.00M$146.00M$178.00M$216.00M$167.00M$132.00M$140.00M$198.00M
    Free cash flow$717.00M$538.00M$291.00M$732.00M$798.00M$459.00M$337.00M$689.00M$784.00M$370.00M$455.00M$699.00M
    Last 12 quarters

    Frequently Asked Questions About ZTS

    What is Zoetis' annual revenue?

    Zoetis reported revenue of $9.47B for the fiscal year ended Dec 31, 2025.

    How fast is Zoetis' revenue growing?

    Revenue was up 2.3% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 5.4%.

    Is Zoetis profitable?

    Yes. Zoetis reported net income of $2.67B for the fiscal year ended Dec 31, 2025, with a net margin of 28.2%.

    How much free cash flow does ZTS generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $2.90B minus capital expenditures of $621.00M produced free cash flow of $2.28B.

    How much debt does Zoetis have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $9.04B, short-term debt of $0 and cash and equivalents of $2.45B.